Canadian Agency for Drugs and Technologies in Health. (2017). Pharmacoeconomic review report Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on behalf of Icon Canada Inc.). Canadian Agency for Drugs and Technologies in Health.
Chicago Style (17th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on Behalf of Icon Canada Inc.). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.
MLA (9th ed.) CitationCanadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Travoprost 0.003% (Izba) (Novartis Pharmaceuticals Canada Inc. on Behalf of Icon Canada Inc.). Canadian Agency for Drugs and Technologies in Health, 2017.